We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

2 hedge funds and large institutions have $42.1K invested in Global Blood Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 239 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 247 → 2 (-245)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $4.73B → $42.1K (-$4.73B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 239

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-245
Holders Change %
-99.19%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
239
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$428M
2
BlackRock
BlackRock
New York
-$323M
3
BBA
Baker Bros. Advisors
New York
-$254M
4
PCM
Pentwater Capital Management
Florida
-$218M
5
State Street
State Street
Massachusetts
-$162M
Name Holding Trade Value Shares
Change 		Change in
Stake
BTI
1
Blue Trust Inc
Georgia
$42K – – –
HNB
2
Huntington National Bank
Ohio
$68 -$15.3K -223 -100%
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$428M -6,282,173 Closed
BlackRock
4
BlackRock
New York
– -$323M -4,749,863 Closed
BBA
5
Baker Bros. Advisors
New York
– -$254M -3,732,502 Closed
PCM
6
Pentwater Capital Management
Florida
– -$218M -3,200,000 Closed
State Street
7
State Street
Massachusetts
– -$162M -2,384,677 Closed
PA
8
Perceptive Advisors
New York
– -$158M -2,322,247 Closed
JP Morgan Chase
9
JP Morgan Chase
New York
– -$157M -2,304,636 Closed
Fidelity International
10
Fidelity International
Bermuda
– -$154M -2,263,000 Closed
UOC
11
UBS O'Connor
Illinois
– -$152M -2,238,787 Closed
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
– -$149M -2,190,686 Closed
Goldman Sachs
13
Goldman Sachs
New York
– -$116M -1,706,600 Closed
Citigroup
14
Citigroup
New York
– -$108M -1,586,334 Closed
GCL
15
Glazer Capital LLC
New York
– -$96.2M -1,412,219 Closed
PBA
16
Paradigm Biocapital Advisors
New York
– -$80.1M -1,175,879 Closed
Two Sigma Advisers
17
Two Sigma Advisers
New York
– -$78.5M -1,152,900 Closed
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
– -$78.4M -1,151,518 Closed
Geode Capital Management
19
Geode Capital Management
Massachusetts
– -$77.8M -1,142,444 Closed
Norges Bank
20
Norges Bank
Norway
– -$65.4M -960,504 Closed
MF
21
Magnetar Financial
Illinois
– -$56.5M -829,531 Closed
AAM
22
Alpine Associates Management
Florida
– -$50.6M -743,397 Closed
TAL
23
TIG Advisors LLC
New York
– -$47.4M -696,420 Closed
KL
24
KIM LLC
Kansas
– -$44.9M -660,000 Closed
WIC
25
Water Island Capital
New York
– -$44.2M -649,242 Closed
1
2 3 4 5

GBT Hedge Fund Activity: Q4 2022 in Review

2 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q4 2022, worth a combined $42.1K — down 100% from $4.73B a quarter earlier.

Sellers outnumbered buyers: 239 funds closed out of GBT and 0 opened new positions — a net loss of 239 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $428M sold.

  • 2 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q4 2022, down from 247 in Q3 2022.
  • Funds reported $42.1K of Global Blood Therapeutics, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Global Blood Therapeutics, Inc. positions in Q4 2022 and 239 closed out, a net change of -239 holders.
  • The largest Global Blood Therapeutics, Inc. seller in Q4 2022 was Vanguard Group, an estimated $428M sold.

Based on aggregated 13F filings for Q4 2022.